IL17A and psoriasis: The levels of IL-6, TNFα and IL-17 were significantly reduced as compared to the vehicle group, suggesting SHR168442 suppressed the production of Th17 pathway related cytokines in IL-23-induced Psoriasis-like skin inflammation mice.